Tissues in embryonic organisms are created by the constant reorganization of cells. Both changes in cell shape and diversity among cells affect morphogenesis, or the development of tissues and organs.

Camizestrant combined with CDK4/6 inhibitors improved progression-free survival in HR+/HER2- advanced breast cancer with ESR1 mutations in the SERENA-6 trial.

Immunohistochemistry showed immunoreaction to aromatase in cells of intertubular space. Confirming these findings, it was possible to observe a type of intertubular cell in several regions of ...

Moreover, melatonin also reduced the number of apoptotic Leydig cells and spermatogonia, aromatase expression, and estradiol level, while increasing the expression of steroid hormone synthases ...

Lymphocytosis is a higher-than-usual count of a type of white blood cell called lymphocytes. Smudge cells are damaged white blood cells that suggest that your blood cells are more fragile. Learn more.

Use of an aromatase inhibitor instead of tamoxifen reduced the risk for breast cancer recurrence among premenopausal women with ER-positive disease who received ovarian suppression, according to a ...

Orphagen Presents Preclinical Efficacy Data at AACR 2022 on OR-449, a First-in-Class SF-1 Inhibitor, for the Treatment of Leydig Cell Tumors ...

Men with late-onset hypogonadism could eventually be treated with stem cells programmed to develop into Leydig cells that secrete testosterone, suggests a new Japanese study.

Leydig cells are responsible for producing the male hormone (testosterone), and it is hoped that Leydig cell transplants could serve as a treatment for late-onset hypogonadism in the future.

Leydig cells are responsible for producing the male hormone (testosterone), and it is hoped that Leydig cell transplants could serve as a treatment for late-onset hypogonadism in the future.